MMED is a screaming buy to me right now.

Low end price target for me is $8, high end price target is $35.. I know , crazy right. But I mean it

They have a great team, from investors to management to directors of clinical trials. Their current clinical trial leads are former directors at Johnson & Johnson, meaning MMED is going to have direct access to get their drugs into the hands of big pharma. Why swim upstream when you can go with the flow .

If you don't own this stock I think you probably should. There is money to be made here, and we might still be waiting for a 5x bagger!

**opinions are my own, I am not a financial advisor and will not be a financial advisor. Do your own due diligence or seek professional guidance before buying**